We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$36.4M
AUM Growth
–
Cap. Flow
+$37.7M
Cap. Flow %
103.47%
Top 10 Hldgs %
37.91%
Holding
76
New
76
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MMP
Magellan Midstream Partners, L.P.
MMP
+$2.74M
2
WMB icon
Williams Companies
WMB
+$2.23M
3
BPL
Buckeye Partners, L.P.
BPL
+$1.63M
4
EPD icon
Enterprise Products Partners
EPD
+$1.45M
5
AEGR
Aegerion Pharmaceuticals
AEGR
+$782K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 45.69%
2 Energy 26.92%
3 Utilities 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMP
1
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2.87M 7.89%
+42,311
New +$2.74M
ETP
2
CALL
DELISTED
Energy Transfer Partners L.p.
ETP
$1.85M 5.09%
+55,000
New +$2.16M
BPL
3
DELISTED
Buckeye Partners, L.P.
BPL
$1.64M 4.51%
+24,889
New +$1.63M
WMB icon
4
Williams Companies
WMB
$91.4B
$1.64M 4.5%
+63,805
New +$2.23M
EPD icon
5
Enterprise Products Partners
EPD
$84.1B
$1.43M 3.91%
+55,762
New +$1.45M
WMB icon
6
CALL
Williams Companies
WMB
$91.4B
$1.16M 3.18%
+45,000
New +$1.57M
EPD icon
7
CALL
Enterprise Products Partners
EPD
$84.1B
$1.15M 3.16%
+45,000
New +$1.17M
OMER icon
8
Omeros
OMER
$694M
$696K 1.91%
+44,237
New +$611K
KERX
9
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$689K 1.89%
+136,472
New +$648K
WES
10
DELISTED
Western Gas Partners Lp
WES
$680K 1.87%
+14,300
New +$688K
AEGR
11
DELISTED
Aegerion Pharmaceuticals
AEGR
$656K 1.8%
+64,959
New +$782K
SGEN
12
DELISTED
Seagen Inc. Common Stock
SGEN
$653K 1.79%
+14,541
New +$605K
IONS icon
13
Ionis Pharmaceuticals
IONS
$8.89B
$647K 1.78%
+10,447
New +$564K
NKTR icon
14
Nektar Therapeutics
NKTR
$2.22B
$645K 1.77%
+2,551
New +$525K
PGNX
15
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$636K 1.75%
+103,807
New +$681K
VNDA icon
16
Vanda Pharmaceuticals
VNDA
$324M
$624K 1.71%
+67,021
New +$669K
ARNA
17
DELISTED
Arena Pharmaceuticals Inc
ARNA
$614K 1.69%
+32,311
New +$659K
ALXN
18
DELISTED
Alexion Pharmaceuticals
ALXN
$604K 1.66%
+3,167
New +$553K
GEL icon
19
Genesis Energy
GEL
$1.82B
$598K 1.64%
+16,278
New +$631K
AMGN icon
20
Amgen
AMGN
$197B
$592K 1.62%
+3,644
New +$573K
GILD icon
21
Gilead Sciences
GILD
$166B
$588K 1.61%
+5,810
New +$605K
PSXP
22
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$588K 1.61%
+9,581
New +$556K
CELG
23
DELISTED
Celgene Corp
CELG
$585K 1.61%
+4,884
New +$565K
ANAC
24
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$581K 1.59%
+5,147
New +$567K
MDCO
25
DELISTED
Medicines Co
MDCO
$572K 1.57%
+15,331
New +$579K
1
2 3 4

Similar funds

AMIM
Aull & Monroe Investment Management Mobile, Alabama $215M AUM 28.37% 1-Year Est. Return
EFS
Econ Financial Services Harrisburg, Pennsylvania $215M AUM 6.73% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
OC
Optima Capital Beaverton, Oregon $215M AUM 17.28% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return

Virtus ETF Advisers's Q4 2015 Portfolio in Review

Q4 2015 is the first quarter with a 13F filing on record for Virtus ETF Advisers, which disclosed 76 positions worth $36.4M. Its ten largest holdings account for 38% of the portfolio.

Its largest position is Magellan Midstream Partners, L.P.: 42,311 shares worth $2.87M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, followed by Energy and Utilities.

  • Virtus ETF Advisers's largest Q4 2015 buy was Magellan Midstream Partners, L.P.: 42,311 shares worth $2.87M.
  • Virtus ETF Advisers's ten largest holdings make up 38% of its $36.4M portfolio in Q4 2015.
  • Virtus ETF Advisers disclosed 76 positions in Q4 2015, its first 13F filing on record.

Based on Virtus ETF Advisers's 13F filing for Q4 2015, filed 16 Feb 2016.